275 related articles for article (PubMed ID: 16213142)
1. Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses.
Allen SH; Johns BA; Gudmundsson KS; Freeman GA; Boyd FL; Sexton CH; Selleseth DW; Creech KL; Moniri KR
Bioorg Med Chem; 2006 Feb; 14(4):944-54. PubMed ID: 16213142
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolopyridine antiherpetics: SAR of C2' and C7 amine substituents.
Johns BA; Gudmundsson KS; Turner EM; Allen SH; Samano VA; Ray JA; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Creech KL; Moniri KR
Bioorg Med Chem; 2005 Apr; 13(7):2397-411. PubMed ID: 15755642
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
4. Pyrazolopyridines with potent activity against herpesviruses: effects of C5 substituents on antiviral activity.
Gudmundsson KS; Johns BA; Allen SH
Bioorg Med Chem Lett; 2008 Feb; 18(3):1157-61. PubMed ID: 18086523
[TBL] [Abstract][Full Text] [Related]
5. Pyrazolo[1,5-a]pyridine antiherpetics: effects of the C3 substituent on antiviral activity.
Johns BA; Gudmundsson KS; Allen SH
Bioorg Med Chem Lett; 2007 May; 17(10):2858-62. PubMed ID: 17350256
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Weatherhead J
Bioorg Med Chem Lett; 2009 Oct; 19(19):5689-92. PubMed ID: 19700316
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors.
Bharate SB; Mahajan TR; Gole YR; Nambiar M; Matan TT; Kulkarni-Almeida A; Balachandran S; Junjappa H; Balakrishnan A; Vishwakarma RA
Bioorg Med Chem; 2008 Aug; 16(15):7167-76. PubMed ID: 18625560
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.
Leal B; Afonso IF; Rodrigues CR; Abreu PA; Garrett R; Pinheiro LC; Azevedo AR; Borges JC; Vegi PF; Santos CC; da Silveira FC; Cabral LM; Frugulhetti IC; Bernardino AM; Santos DO; Castro HC
Bioorg Med Chem; 2008 Sep; 16(17):8196-204. PubMed ID: 18701299
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis.
de Mello H; Echevarria A; Bernardino AM; Canto-Cavalheiro M; Leon LL
J Med Chem; 2004 Oct; 47(22):5427-32. PubMed ID: 15481980
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity.
Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y
Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
Lin R; Connolly PJ; Lu Y; Chiu G; Li S; Yu Y; Huang S; Li X; Emanuel SL; Middleton SA; Gruninger RH; Adams M; Fuentes-Pesquera AR; Greenberger LM
Bioorg Med Chem Lett; 2007 Aug; 17(15):4297-302. PubMed ID: 17532631
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
Mitchell CJ; Ballantine SP; Coe DM; Cook CM; Delves CJ; Dowle MD; Edlin CD; Hamblin JN; Holman S; Johnson MR; Jones PS; Keeling SE; Kranz M; Lindvall M; Lucas FS; Neu M; Solanke YE; Somers DO; Trivedi NA; Wiseman JO
Bioorg Med Chem Lett; 2010 Oct; 20(19):5803-6. PubMed ID: 20732811
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.
Barreiro EJ; Camara CA; Verli H; Brazil-Más L; Castro NG; Cintra WM; Aracava Y; Rodrigues CR; Fraga CA
J Med Chem; 2003 Mar; 46(7):1144-52. PubMed ID: 12646025
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2.
Paruch K; Dwyer MP; Alvarez C; Brown C; Chan TY; Doll RJ; Keertikar K; Knutson C; McKittrick B; Rivera J; Rossman R; Tucker G; Fischmann TO; Hruza A; Madison V; Nomeir AA; Wang Y; Lees E; Parry D; Sgambellone N; Seghezzi W; Schultz L; Shanahan F; Wiswell D; Xu X; Zhou Q; James RA; Paradkar VM; Park H; Rokosz LR; Stauffer TM; Guzi TJ
Bioorg Med Chem Lett; 2007 Nov; 17(22):6220-3. PubMed ID: 17904841
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N
Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486
[TBL] [Abstract][Full Text] [Related]
19. Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors.
Stevens KL; Jung DK; Alberti MJ; Badiang JG; Peckham GE; Veal JM; Cheung M; Harris PA; Chamberlain SD; Peel MR
Org Lett; 2005 Oct; 7(21):4753-6. PubMed ID: 16209527
[TBL] [Abstract][Full Text] [Related]
20. Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators.
Griebenow N; Schirok H; Mittendorf J; Straub A; Follmann M; Stasch JP; Knorr A; Schlemmer KH; Redlich G
Bioorg Med Chem Lett; 2013 Mar; 23(5):1197-200. PubMed ID: 23385209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
